Clinical Trial Update: Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating targeted busulfan and fludarabine in pediatric acute myeloid leukemia undergoing hematopoietic stem cell transplantatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hematopoietic Stem Cell Transplantation | Phase 2 | Status: UNKNOWN